Consensus Moderna, Inc.

Stocks

MRNA

US60770K1079

Pharmaceuticals

Market Closed - Nasdaq 00:00:00 13/11/2026 +03			5-day change	1st Jan Change
231.35 ^USD	-6.97%		-4.19%	+684.50%

11-12	Moderna Sees $4 Billion Cash Costs in 2027	MT
11-12	Argus Adjusts Price Target on Moderna to $280 From $180	MT

Evolution of the Average Target: Moderna, Inc.

Evolution of the Target Price: Moderna, Inc.

Changes in Analyst Recommendations: Moderna, Inc.

3746add8082a.S1Asr7vpaM67BSMzan1OPk96VCw26bSpxxQ6K0PB8tc.LWhW18KEUKvOQRJlIRc6Bnk3G2BCitPOjiZVGRuqh7kxPXj1wrlYpI9Gag~633740effe27d01907b80a7d19088ef4

Analysts' recommendations: Moderna, Inc.

11-12	Argus Adjusts Price Target on Moderna to $280 From $180	MT
11-11	Rothschild & Co Redburn Adjusts Price Target on Moderna to $82 From $81	MT
11-09	Goldman Sachs Adjusts Price Target on Moderna to $195 From $137	MT
11-09	Piper Sandler Adjusts Price Target on Moderna to $305 From $230	MT
11-06	TD Cowen Adjusts Moderna Price Target to $110 From $90, Maintains Hold Rating	MT
11-06	RBC Capital Adjusts Moderna Price Target to $145 From $130, Maintains Sector Perform Rating	MT
10-27	William Blair Downgrades Moderna to Market Perform From Outperform	MT
10-27	William Blair Downgrades Moderna to Market Perform	MT
10-27	William Blair Initiates Moderna at Market Perform	MT
10-26	A Week of Reckoning for Wall Street
10-26	Analyst recommendations: Block, Fair Isaac, Ross Stores, Spotify, Tesla…
10-26	Piper Sandler Adjusts Price Target on Moderna to $230 From $167	MT
10-23	Analyst recommendations: Qiagen, Skydance, Moderna, PG&E, ServiceNow…
10-22	Jefferies Adjusts Price Target on Moderna to $215 From $150	MT
10-22	Analyst recommendations: Block, Halliburton, Qiagen, Tesla, CoreWeave…
10-21	TD Cowen Adjusts Price Target on Moderna to $90 From $40	MT
10-21	Analyst recommendations: Cirrus Logic, Fortinet, Ge Aerospace, Moderna, Nebius, Oklo…
10-19	Oddo BHF Adjusts Moderna Price Target to $251 From $170	MT
10-09	BofA Securities Adjusts Price Target on Moderna to $200 From $170, Maintains Neutral Rating	MT
10-08	Evercore ISI Adjusts Price Target on Moderna to $80 From $50	MT
10-07	Morgan Stanley Adjusts Price Target on Moderna to $95 From $89	MT
10-02	And in the End, Europe Takes the Hit
09-30	Citigroup Downgrades Moderna to Sell From Neutral, Adjusts Price Target to $80 From $60	MT
09-11	Berenberg Boosts Price Target on Moderna to $100 From $45, Keeps Hold Rating	MT
09-09	Moderna Set for 3 Near-Term INT Data Readouts, UBS Says	MT

More recommendations

Biopharmaceuticals

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	MODERNA, INC.					-36.28%
	ELI LILLY AND COMPANY					+1.12%
	JOHNSON & JOHNSON					-0.36%
	ABBVIE INC.					+5.31%
	ROCHE HOLDING AG					-1.37%
	MERCK & CO., INC.					+9.75%
	NOVARTIS AG					-3.31%
	ASTRAZENECA PLC					+16.26%
	AMGEN INC.					-7.76%
	GILEAD SCIENCES, INC.					+2.97%
	Average					-1.37%
	Weighted average by Cap.					+1.34%